Medical Implants Businesses for Sale and Investment Opportunities

Established medical equipment and surgical implants supply business based in Dubai, actively seeking investment to expand its operations. - Boasts over 500 supply contracts, ensuring a robust distribution network across 20 hospitals, 50 clinics, and 500 pharmacies. - Offers a diverse product portfolio including ortho-spine implants, artificial saliva, multivitamins, and various medical equipment and consumables. - All products are FDA-compliant, providing assurance of quality and safety to healthcare providers and patients. - The company's promoter brings 23 years of procurement and supply chain management experience within the medical industry, enhancing operational effectiveness. - Strong relationship management with healthcare entities, including physicians, surgeons, and home health service providers, facilitating smooth transactions and repeat business. - Target markets include chronic patients needing artificial saliva and patients requiring orthopaedic spinal implants, addressing critical healthcare needs. - Business is based in Dubai. Promoter is in India for a few days and will be back in Dubai in a few days. - We do not require high manpower as we only supply the products and don't manufacture them.

Established player in the medical implants industry with a strategic location in Greece, facilitating easy access to European markets. - Workforce of 20 skilled employees dedicated to the design and manufacturing of high-quality medical implants for surgical use. - Comprehensive product portfolio includes specialized implants and surgical products catering to fractures and various surgical procedures. - In-house manufacturing capabilities complemented by strategic partnerships with contract manufacturers to ensure supply chain efficiency. The company also imports certain implants from other providers. - Current contracts with hospitals in Greece, securing coverage for approximately 80% of the national demand for medical implants. - Significant potential for international expansion, with existing capacity to export to clients and distributors beyond Greece's borders.

The company develops human bone tissue for implantation in patients with bone fractures, instability in the spine, or bone gaps following trauma or previous surgery. - We are currently in the development stage, hence there is no revenue generation and the figures are not given. - The product is tailored for a specific patient because it uses bone cells and blood components. - Therefore, this product is individualized for a patient and should not be rejected. - We have already successfully passed the FDA pre-IND process with a positive feedback. - Patents have already been issued in the EU, USA, Switzerland, and Israel. - The method, its efficiency, and safety were described in two scientific papers published in. Highly ranked peer-reviewed journals. - Have conducted preliminary testing to demonstrate the feasibility of the product. - Led by a highly qualified CEO who is an expert in bone cell culturing and has multiple qualifications like MD, MOrthop, MBA, and FRCS (England). - It is expected to require an additional 2 years after securing funding to obtain necessary approvals from the FDA and European authorities. - The bone grafting market is estimated to be above USD 10 billion. - Since currently there is no clinically used method for personalized bone grafting material supplementation, the appearance of such a product will even increase the market evaluation.

The company develops human bone tissue for implantation in patients with bone fractures, instability in the spine, or bone gaps following trauma or previous surgery. - We are currently in the development stage, hence there is no revenue generation and the figures are not given. - The product is tailored for a specific patient because it uses bone cells and blood components. - Therefore, this product is individualized for a patient and should not be rejected. - We have already successfully passed the FDA pre-IND process with a positive feedback. - Patents have already been issued in the EU, USA, Switzerland, and Israel. - The method, its efficiency, and safety were described in two scientific papers published in. Highly ranked peer-reviewed journals. - Have conducted preliminary testing to demonstrate the feasibility of the product. - Led by a highly qualified CEO who is an expert in bone cell culturing and has multiple qualifications like MD, MOrthop, MBA, and FRCS (England). - It is expected to require an additional 2 years after securing funding to obtain necessary approvals from the FDA and European authorities. - The bone grafting market is estimated to be above USD 10 billion. - Since currently there is no clinically used method for personalized bone grafting material supplementation, the appearance of such a product will even increase the market evaluation.

A Colombian company specializing in applied research, prototypes and the protection of intellectual property and rights. designs innovative solutions and transforms them into cost effective, commercially viable new products. - The company is capable of identifying market needs and developing cost-efficient products with innovative approaches and proprietary technology. - Currently focused on the development and manufacture of a new patented osteosynthesis implant for broken bones. - The company has established agreements with universities and research groups to enhance its innovative and developing capacity. - Has a strong nucleus of inventors and experts in various areas including economics, electronic engineering, mechanical systems, business and international relations, machine tooling, and intellectual property. - The revenue model is project-based, with an average of 2-3 projects per year and an average project duration of 1 to 2 years. Upon developing the new implants, the revenue model will be through supply of these products. - The company's current pipeline includes 3 projects in various stages of research and development. - Clients are mainly universities and research centres. Has established relations with more than fifteen service provider companies, collaborating with new companies for the development of a new product when needed.

Innovative wheelchair solution: Developed a groundbreaking wheelchair with integrated defecation cleaning and hygiene features, addressing the specific needs of the mobility-impaired population. - Patent portfolio: Secured a strong intellectual property position with 7 filed patents, encompassing both design patents and trademarks, establishing the company as a leader in healthcare technology innovation. - Positive impact: Already improved the lives of 250+ individuals with mobility challenges, demonstrating a tangible and positive impact on the quality of life for the target demographic. - Product pipeline: Currently working on the development of a mass-market wheelchair priced at Rs 15,000 and a motorized chair with defecation support, showcasing a commitment to continuous innovation and expanding product offerings. - Strong financial model: Boasts a robust financial model with a gross margin exceeding 40%, ensuring an attractive return on investment for stakeholders and investors. - Customer satisfaction: Proven track record of delivering high levels of customer satisfaction throughout India, contributing to the rapid acceptance and adoption of innovative solutions. - Shark Tank success: Distinguished as one of the few companies to secure a 5 Shark Deal on Shark Tank India, underscoring the business's viability and appeal to seasoned investors. - Global recognition: Acknowledged and accepted by the Australian government, indicating the company's potential for international success and recognition beyond the domestic market. - 80% of revenue generated through B2B sales. - Company currently operating at break-even. All other details will be disclosed after the introduction.

Our business is engaged in the manufacturing of surgical instruments, medical equipment, and ortho implants. - We have a network of 5 vendors for raw materials. - On average, we have a production capacity of manufacturing 10 lakh units of equipment per month. - We are selling our products in 5 states, in Chhattisgarh, MP, UP, Odisha, and Maharashtra. - Have tied up with 52 sales agents, and 19 dealers.

Certified Dental Lab in operation at Mysore, Karnataka, India. Operating since 12 years, the lab caters to the needs of Dental professionals in Mysore, Kodagu, Mandya and Chamarajnagar Districts. Served around 200 dentists and doctors till date with 80 regular doctors. Machinery includes ceramic furnaces of German made worth 2-3 lakhs, 4 high speed motors worth 1 lakh each, backup facility genset and UPS. Buyer will need to invest in hiring manpower and develop marketing strategy to flourish the business. Also willing to explore rental option, if someone doesnt want to buy the unit outright.